What is Noble Financial’s Estimate for Nukkleus Q3 Earnings?

Nukkleus Inc. (NASDAQ:DFNS) – Stock analysts at Noble Financial boosted their Q3 2026 earnings estimates for Nukkleus in a research report issued on Monday, August 24th. Noble Financial analyst J. Gomes now forecasts that the company will post earnings of ($2.16) per share for the quarter, up from their prior forecast of ($2.70). Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($4.21) per share. Noble Financial also issued estimates for Nukkleus’ Q4 2026 earnings at ($1.75) EPS, FY2026 earnings at ($3.90) EPS, FY2027 earnings at ($5.09) EPS and FY2028 earnings at $0.00 EPS.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The company had revenue of $4.00 million during the quarter, compared to analyst estimates of $4.50 million.

Several other equities research analysts have also recently commented on DFNS. Wall Street Zen raised Nukkleus from a “strong sell” rating to a “sell” rating in a report on Sunday. Weiss Ratings lowered Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Nukkleus Stock Performance

DFNS stock opened at $11.88 on Thursday. The company has a 50-day simple moving average of $24.10 and a 200 day simple moving average of $83.75. The company has a market capitalization of $12.00 million, a P/E ratio of -0.03 and a beta of -5.80. The company has a quick ratio of 0.11, a current ratio of 0.14 and a debt-to-equity ratio of 0.07. Nukkleus has a fifty-two week low of $3.70 and a fifty-two week high of $1,948.75.

Institutional Investors Weigh In On Nukkleus

Institutional investors and hedge funds have recently modified their holdings of the stock. BNP Paribas Financial Markets purchased a new stake in shares of Nukkleus during the second quarter valued at $56,000. UBS Group AG raised its holdings in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after buying an additional 15,223 shares during the period. Ausdal Financial Partners Inc. acquired a new stake in Nukkleus during the 3rd quarter worth about $105,000. Geode Capital Management LLC lifted its stake in Nukkleus by 193.7% during the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after buying an additional 82,252 shares in the last quarter. Finally, LPL Financial LLC purchased a new position in Nukkleus during the 4th quarter worth approximately $120,000. 12.47% of the stock is owned by institutional investors and hedge funds.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.